MC TOXICOLOGY CONSULTING GMBH -  

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 7.988.724 3.643 1
2018 0 6.249.104 156.873 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION FRANCAISE DE CRIGLER NAJJAR1
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII1
BLUST VOLKER1
CATALYZE BV1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
GENETHON1
GENOSAFE SAS1
IMMUNOLOGIK1
MEDIZINISCHE HOCHSCHULE HANNOVER1
METRIOPHARM1
METRIOPHARM DEUTSCHLAND1
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'1
UNIVERSITY OF LEICESTER1

Constancy:

Total number of partners: 15
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 15
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-08-01Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity iMPactparticipant7.988.7246
2018-01-01Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome CureCNparticipant6.249.10411